Promoter methylation status of <i>ASC/TMS1/PYCARD</i> is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC).
第一作者:
Maja,Šutić
第一单位:
Ruđer Bošković Institute, Division for Molecular Medicine, Zagreb, Croatia.
作者:
DOI
10.21037/tlcr.2019.12.08
PMID
32010578
发布时间
2022-04-12
- 浏览2

Translational lung cancer research
2019年8卷6期
1000-1015页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文